Skip to main content

American Journal of Physiology Archives

A target to heal tiny lungs

Feb. 23, 2017—The protein beta-catenin may be a good target for therapies to treat lung disease that is a common complication of preterm birth.

Read more

Health and Medicine Reporter Research


Making human beta cells reproduce

Dec. 8, 2016—A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells.

Read more

Health and Medicine Reporter Research


In search of new asthma therapies

Aug. 15, 2016—A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies.

Read more

Health and Medicine Reporter Research


Fetal impact of antidepressants

Aug. 3, 2016—Antidepressant use during pregnancy is common. Fetal exposure to the class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) is associated with the life-threatening condition PPHN (persistent pulmonary hypertension of the newborn), but a causal link has not been established.

Read more

Health and Medicine Reporter Research


Tiny model of diabetes

Feb. 20, 2015—Vanderbilt University researchers have created a zebrafish model of skeletal muscle insulin resistance that could help improve diabetes treatment.

Read more

Health and Medicine Reporter Research


Antibiotics, fetal vessel defect linked

Oct. 15, 2014—Certain antibiotics increase the risk of a congenital heart disorder called patency of the ductus arteriosis.

Read more

Health and Medicine Reporter Research


Patient-derived stem cells shed light on pulmonary hypertension

Sep. 16, 2014—Stem cells derived from patients with pulmonary arterial hypertension provide a unique resource for studying the molecular defects that cause the disease and testing potential therapies.

Read more

Health and Medicine Reporter Research